Results 261 to 270 of about 7,177,989 (337)
TNFRSF19 is an epigenetically silenced regulator of mitophagy in triple‐negative breast cancer. TNFRSF19 deficiency activates the TGFBR1–SMAD3–PINK1 axis to promote mitophagy and confer doxorubicin resistance, whereas decitabine‐mediated restoration of TNFRSF19 suppresses mitophagy and enhances doxorubicin sensitivity, revealing a targetable epigenetic–
Shiyang Liu +7 more
wiley +1 more source
Early detection of esophageal squamous cell carcinoma via a CACNA1E-SNTG1 cfDNA methylation signature. [PDF]
Song C +12 more
europepmc +1 more source
In this multicenter prospective study of 158 working‐age patients undergoing curative‐intent surgery for gastric or esophageal cancer, 78.5% were working at 18 months. Postoperative appetite loss, financial difficulties, and ≥ 10% weight loss at 6 months were associated with non‐working status.
Kentaro Goto +18 more
wiley +1 more source
Metastatic Esophageal Squamous Cell Carcinoma of the Femoral Head Masquerading as Brodie's Abscess with Concurrent Methicillin-Resistant Staphylococcus aureus Infection: A Diagnostic Dilemma. [PDF]
Sharma C +4 more
europepmc +1 more source
Identification of a necroptosis-related lncRNA prognostic signature and the hub RBP HNRNPK in esophageal squamous cell carcinoma. [PDF]
Zheng S +6 more
europepmc +1 more source
ABSTRACT Background Nonmelanoma skin cancer (NMSC) is one of the most common malignancies worldwide, with increasing incidence. Type 2 diabetes mellitus (T2DM) is a prevalent comorbidity that may adversely affect cancer prognosis through shared metabolic and inflammatory pathways.
Junjie Huang +8 more
wiley +1 more source
Real‐world Validation of the MAGIC‐D Index. The MAGIC‐D index was validated using real‐world data from patients with unresectable BTC who received durvalumab‐chemotherapy at Tongji Hospital. The risk stratification ability of the MAGIC‐D index for patient survival was improved after incorporating Ki67 and CA 19‐9.
Tianao Zhan +9 more
wiley +1 more source
Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma. [PDF]
Song J.
europepmc +1 more source
In PTC cells, METTL7B stabilizes PLEKHA4 mRNA through m6A modification; upregulated PLEKHA4 binds KLHL12 and inhibits KLHL12‐mediated ubiquitination and degradation of AURKA, thereby stabilizing AURKA protein. Elevated AURKA suppresses ferroptosis by upregulating GPX4 and xCT while downregulating ACSL4, leading to ferroptosis resistance and enhanced ...
Wei Lin +5 more
wiley +1 more source

